{
  "ticker": "BMRN",
  "success": true,
  "price": {
    "current": 56.99,
    "currency": "USD",
    "day_high": 57.04,
    "day_low": 55.8,
    "52_week_high": 73.51,
    "52_week_low": 50.76
  },
  "market_cap": {
    "value": 10948596736.0,
    "currency": "USD"
  },
  "shares_outstanding": 192114344.0,
  "volume": {
    "last": 2170632,
    "average_30d": 2038917
  },
  "valuation": {
    "pe_ratio": 21.185873,
    "forward_pe": 10.928888,
    "price_to_book": 1.8075423
  },
  "company_info": {
    "name": "BioMarin Pharmaceutical Inc.",
    "sector": "Healthcare",
    "industry": "Biotechnology"
  },
  "balance_sheet": {
    "success": true,
    "period_date": "2025-09-30",
    "total_assets": 7614868000.0,
    "total_liabilities": 1558157000.0,
    "stockholders_equity": 6056711000.0,
    "cash": 1250108000.0,
    "marketable_securities": 227731000.0,
    "total_liquidity": 1477839000.0,
    "total_debt": 604241000.0,
    "long_term_debt": 596663000.0,
    "current_debt": 7578000.0,
    "error": null
  },
  "cash_flow": {
    "success": true,
    "period_date": "2025-09-30",
    "operating_cash_flow": 368685000.0,
    "free_cash_flow": 334935000.0,
    "investing_cash_flow": -330963000.0,
    "financing_cash_flow": -2169000.0,
    "error": null
  },
  "income_statement": {
    "success": true,
    "period_date": "2025-09-30",
    "operating_expense": 682725000.0,
    "research_and_development": 409478000.0,
    "interest_expense": 2579000.0,
    "net_income": -30744000.0,
    "revenue": 776133000.0,
    "gross_profit": 636048000.0,
    "ebitda": -5258000.0,
    "error": null
  },
  "data_quality": {
    "flags": [],
    "has_price": true,
    "has_market_cap": true,
    "has_volume": true,
    "has_balance_sheet": true,
    "has_cash_flow": true,
    "has_income_statement": true
  },
  "provenance": {
    "source": "Yahoo Finance via yfinance",
    "timestamp": "2026-01-29T16:44:35.581956",
    "url": "https://finance.yahoo.com/quote/BMRN",
    "data_hash": "513ec018d2cd4bc5"
  }
}